Search research articles
Contact Us
Filters
Showing results (391-400 of 423) with videos related to
Page
of 43
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2019
A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921)
Yael P Mossé, Elizabeth Fox, David T Teachey, et al.
Annals of Surgical Oncology
|
September 1, 2025
ASO Visual Abstract: Evaluating Variation in Lymph Node Sampling During Sentinel Lymph Node Biopsy for Melanoma
Crystal D Taylor, Vanessa S Niba, Alison S Baskin, et al.
Biorxiv : the Preprint Server for Biology
|
September 15, 2025
Mitfa-Independent Melanocyte Progenitors are Highly Susceptible to GNAQ-induced Uveal Melanoma in Adult Zebrafish
Julius I Yevdash, Delaney Robinson, Rachel Moore, et al.
Annals of Surgical Oncology
|
August 16, 2025
Evaluating Variation in Lymph Node Sampling During Sentinel Lymph Node Biopsy for Melanoma
Crystal D Taylor, Vanessa S Niba, Alison S Baskin, et al.
Developmental Cell
|
May 2, 2025
Sumoylated Etv1 establishes mouse mammary cancer stem cells that support tumorigenesis by non-stem cancer cells
Zhijie Li, Kelsey E Koch, Dakota T Thompson, et al.
JCO Oncology Advances
|
May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study
Damon R Reed, Katherine A Janeway, Charles G Minard, et al.
Annals of Surgery
|
June 11, 2025
First National Effort to Optimize the Performance of Cancer Surgery by the American College of Surgeons Commission on Cancer and Cancer Surgery Standards Program: Early Results After Implementation of the Operative Standards
Matthew H G Katz, Amanda B Francescatti, Timothy W Mullett, et al.
Oncogene
|
February 12, 2020
Cancer cell-intrinsic function of CD177 in attenuating β-catenin signaling
Paige N Kluz, Ryan Kolb, Qing Xie, et al.
Nature Cell Biology
|
February 21, 2018
RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix-detached cells
Mark A Hawk, Cassandra L Gorsuch, Patrick Fagan, et al.
Cancer Medicine
|
December 19, 2020
Metabolic response as assessed by <sup>18</sup> F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
Douglas J Harrison, Yueh-Yun Chi, Jing Tian, et al.
Page
of 43
Search research articles
Search
Showing results (391-400 of 423) with videos related to
Sort By:
Page
of 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2019
A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921)
Yael P Mossé, Elizabeth Fox, David T Teachey, et al.
Annals of Surgical Oncology
|
September 1, 2025
ASO Visual Abstract: Evaluating Variation in Lymph Node Sampling During Sentinel Lymph Node Biopsy for Melanoma
Crystal D Taylor, Vanessa S Niba, Alison S Baskin, et al.
Biorxiv : the Preprint Server for Biology
|
September 15, 2025
Mitfa-Independent Melanocyte Progenitors are Highly Susceptible to GNAQ-induced Uveal Melanoma in Adult Zebrafish
Julius I Yevdash, Delaney Robinson, Rachel Moore, et al.
Annals of Surgical Oncology
|
August 16, 2025
Evaluating Variation in Lymph Node Sampling During Sentinel Lymph Node Biopsy for Melanoma
Crystal D Taylor, Vanessa S Niba, Alison S Baskin, et al.
Developmental Cell
|
May 2, 2025
Sumoylated Etv1 establishes mouse mammary cancer stem cells that support tumorigenesis by non-stem cancer cells
Zhijie Li, Kelsey E Koch, Dakota T Thompson, et al.
JCO Oncology Advances
|
May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study
Damon R Reed, Katherine A Janeway, Charles G Minard, et al.
Annals of Surgery
|
June 11, 2025
First National Effort to Optimize the Performance of Cancer Surgery by the American College of Surgeons Commission on Cancer and Cancer Surgery Standards Program: Early Results After Implementation of the Operative Standards
Matthew H G Katz, Amanda B Francescatti, Timothy W Mullett, et al.
Oncogene
|
February 12, 2020
Cancer cell-intrinsic function of CD177 in attenuating β-catenin signaling
Paige N Kluz, Ryan Kolb, Qing Xie, et al.
Nature Cell Biology
|
February 21, 2018
RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix-detached cells
Mark A Hawk, Cassandra L Gorsuch, Patrick Fagan, et al.
Cancer Medicine
|
December 19, 2020
Metabolic response as assessed by <sup>18</sup> F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
Douglas J Harrison, Yueh-Yun Chi, Jing Tian, et al.
Page
of 43